Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10080789 Programming of cells for tolerogenic therapies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
May 5, 2016
Date of Patent
September 25, 2018
Patent Application Number
15147442
Patent Citations Received
‌
US Patent 11998593 Combination vaccine devices and methods of killing cancer cells
0
‌
US Patent 11278604 Mesoporous silica compositions comprising inflammatory cytokines comprising inflammatory cytokines for modulating immune responses
‌
US Patent 11752238 Recapitulating the hematopoietic niche to reconstitute immunity
‌
US Patent 11786457 Peritumoral and intratumoral materials for cancer therapy
‌
US Patent 10568949 Method of eliciting an anti-tumor immune response with controlled delivery of TLR agonists in porous polymerlc devices
‌
US Patent 10682400 Combination vaccine devices and methods of killing cancer cells
‌
US Patent 11555177 Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10080789
Patent Primary Examiner
‌
Scott Long

Find more entities like US Patent 10080789 Programming of cells for tolerogenic therapies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo